These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 31484544

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cardiovascular magnetic resonance imaging of functional and microstructural changes of the heart in a longitudinal pig model of acute to chronic myocardial infarction.
    Stoeck CT, von Deuster C, Fuetterer M, Polacin M, Waschkies CF, van Gorkum RJH, Kron M, Fleischmann T, Cesarovic N, Weisskopf M, Kozerke S.
    J Cardiovasc Magn Reson; 2021 Sep 20; 23(1):103. PubMed ID: 34538266
    [Abstract] [Full Text] [Related]

  • 3. Diffusion Tensor Cardiovascular Magnetic Resonance in Cardiac Amyloidosis.
    Khalique Z, Ferreira PF, Scott AD, Nielles-Vallespin S, Martinez-Naharro A, Fontana M, Hawkins P, Firmin DN, Pennell DJ.
    Circ Cardiovasc Imaging; 2020 May 20; 13(5):e009901. PubMed ID: 32408830
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tissue mapping by cardiac magnetic resonance imaging for the prognostication of cardiac amyloidosis: A systematic review and meta-analysis.
    Cai S, Haghbayan H, Chan KKW, Deva DP, Jimenez-Juan L, Connelly KA, Ng MY, Yan RT, Yan AT.
    Int J Cardiol; 2024 May 15; 403():131892. PubMed ID: 38382853
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Myocardial tissue characterization in patients with hereditary gelsolin (AGel) amyloidosis using novel cardiovascular magnetic resonance techniques.
    Lehmonen L, Kaasalainen T, Atula S, Mustonen T, Holmström M.
    Int J Cardiovasc Imaging; 2019 Feb 15; 35(2):351-358. PubMed ID: 30848402
    [Abstract] [Full Text] [Related]

  • 14. Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis.
    Baggiano A, Boldrini M, Martinez-Naharro A, Kotecha T, Petrie A, Rezk T, Gritti M, Quarta C, Knight DS, Wechalekar AD, Lachmann HJ, Perlini S, Pontone G, Moon JC, Kellman P, Gillmore JD, Hawkins PN, Fontana M.
    JACC Cardiovasc Imaging; 2020 Jan 15; 13(1 Pt 1):69-80. PubMed ID: 31202744
    [Abstract] [Full Text] [Related]

  • 15. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
    Ntusi NAB, Piechnik SK, Francis JM, Ferreira VM, Matthews PM, Robson MD, Wordsworth PB, Neubauer S, Karamitsos TD.
    JACC Cardiovasc Imaging; 2015 May 15; 8(5):526-536. PubMed ID: 25890584
    [Abstract] [Full Text] [Related]

  • 16. Myocardial extracellular volume quantification in cardiac amyloidosis: a comparative study between cardiac computed tomography and magnetic resonance imaging.
    Hayashi H, Oda S, Kidoh M, Yamaguchi S, Yoshimura F, Takashio S, Usuku H, Nagayama Y, Nakaura T, Ueda M, Tsujita K, Hirai T.
    Eur Radiol; 2024 Feb 15; 34(2):1016-1025. PubMed ID: 37597032
    [Abstract] [Full Text] [Related]

  • 17. Feasibility of Hepatic T1-Mapping and Extracellular Volume Quantification on Routine Cardiac Magnetic Resonance Imaging in Patients with Infiltrative and Systemic Disorders.
    Dolan RS, Stillman AE, Davarpanah AH.
    Acad Radiol; 2022 Apr 15; 29 Suppl 4():S100-S109. PubMed ID: 34702675
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic value of the novel CMR parameter "myocardial transit-time" (MyoTT) for the assessment of microvascular changes in cardiac amyloidosis and hypertrophic cardiomyopathy.
    Chatzantonis G, Bietenbeck M, Florian A, Meier C, Stalling P, Korthals D, Reinecke H, Yilmaz A.
    Clin Res Cardiol; 2021 Jan 15; 110(1):136-145. PubMed ID: 32372287
    [Abstract] [Full Text] [Related]

  • 19. 3D myocardial deformation analysis from cine MRI as a marker of amyloid protein burden in cardiac amyloidosis: validation versus T1 mapping.
    Avitzur N, Satriano A, Afzal M, Narous M, Mikami Y, Hansen R, Dobko G, Flewitt J, Lydell CP, Howarth AG, Chow K, Fine NM, White JA.
    Int J Cardiovasc Imaging; 2018 Dec 15; 34(12):1937-1946. PubMed ID: 30014362
    [Abstract] [Full Text] [Related]

  • 20. Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis.
    Ridouani F, Damy T, Tacher V, Derbel H, Legou F, Sifaoui I, Audureau E, Bodez D, Rahmouni A, Deux JF.
    J Cardiovasc Magn Reson; 2018 Aug 16; 20(1):58. PubMed ID: 30115079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.